• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

14个社区的血压研究。高血压的两阶段筛查。

Blood pressure studies in 14 communities. A two-stage screen for hypertension.

出版信息

JAMA. 1977 May 30;237(22):2385-91. doi: 10.1001/jama.1977.03270490025018.

DOI:10.1001/jama.1977.03270490025018
PMID:576938
Abstract

the Hypertension Detection and Follow-up Program (HDFP) is a community-based national trial to determine whether special programs can improve the treatment for persons with uncontrolled hypertension and reduce morbidity and mortality in wide strata of these patients. A total of 158,906 persons, aged 30 to 69 years, were screened to identify those with a diastolic blood pressure (DBP) of 95 mm Hg or higher. Age-sex-race means and distributions of DBP at a first and a second screen and prevalence rates or actual hypertension by sex, race, and level of control suggest a recently increased awareness of hypertension with more widespread and effective treatment, especially among women, although blacks under treatment had their DBP controlled less frequently. The response to this program of screening and initial follow-up offers encouragement for improved community control of high blood pressure.

摘要

高血压检测与随访项目(HDFP)是一项基于社区的全国性试验,旨在确定特殊项目能否改善血压控制不佳的患者的治疗情况,并降低这类患者广泛群体中的发病率和死亡率。共有158,906名年龄在30至69岁之间的人接受了筛查,以确定那些舒张压(DBP)为95毫米汞柱或更高的人。首次和第二次筛查时DBP的年龄、性别、种族均值和分布,以及按性别、种族和控制水平划分的实际高血压患病率表明,尽管接受治疗的黑人DBP控制频率较低,但随着治疗更加广泛和有效,尤其是在女性中,最近人们对高血压的认识有所提高。对该筛查和初始随访项目的反应为改善社区高血压控制提供了鼓励。

相似文献

1
Blood pressure studies in 14 communities. A two-stage screen for hypertension.14个社区的血压研究。高血压的两阶段筛查。
JAMA. 1977 May 30;237(22):2385-91. doi: 10.1001/jama.1977.03270490025018.
2
Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975.对100万美国人进行高血压筛查。社区高血压评估诊所(CHEC)项目,1973年至1975年。
JAMA. 1976 May 24;235(21):2299-306. doi: 10.1001/jama.235.21.2299.
3
Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group.
J Community Health. 1984 Summer;9(4):314-27.
4
Recent status of detection, treatment, and control of hypertension in the community.
J Community Health. 1979 Winter;5(2):82-93. doi: 10.1007/BF01324010.
5
Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.高血压检测与随访项目的五年研究结果。III. 高血压患者中风发病率的降低。高血压检测与随访项目合作组
JAMA. 1982 Feb 5;247(5):633-8.
6
Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group.
JAMA. 1979 Dec 7;242(23):2572-7. doi: 10.1001/jama.1979.03300230028022.
7
Effects of home telemonitoring and community-based monitoring on blood pressure control in urban African Americans: a pilot study.家庭远程监测和社区监测对城市非裔美国人血压控制的影响:一项试点研究。
Heart Lung. 2001 May-Jun;30(3):191-9. doi: 10.1067/mhl.2001.112684.
8
Incorporating socio-economic and risk factor diversity into the development of an African-American community blood pressure control program.将社会经济和风险因素多样性纳入非裔美国人社区血压控制项目的开发中。
Ethn Dis. 1997 Autumn;7(3):175-83.
9
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.美国成年人群中高血压患病率、知晓率、治疗率和控制率的趋势。来自1960年至1991年健康检查调查的数据。
Hypertension. 1995 Jul;26(1):60-9. doi: 10.1161/01.hyp.26.1.60.
10
Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.当代指南指导下的非裔美国男性和女性及白种人男性和女性的高血压终生风险。
JAMA Cardiol. 2019 May 1;4(5):455-459. doi: 10.1001/jamacardio.2019.0529.

引用本文的文献

1
Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial.以患者为中心的行为经济学干预对高度弱势群体高血压控制的影响:一项随机试验。
J Gen Intern Med. 2020 Jan;35(1):70-78. doi: 10.1007/s11606-019-05269-z. Epub 2019 Sep 12.
2
Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele.血压和降压药物及 APOE ε4 等位基因与阿尔茨海默病痴呆发病风险的关系。
Ann Neurol. 2018 May;83(5):935-944. doi: 10.1002/ana.25228. Epub 2018 May 11.
3
Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations.
定量血压特征的长期平均对遗传关联检测的影响。
Am J Hum Genet. 2014 Jul 3;95(1):49-65. doi: 10.1016/j.ajhg.2014.06.002. Epub 2014 Jun 26.
4
Impact of ovarian function on cardiovascular health in women: focus on hypertension.卵巢功能对女性心血管健康的影响:聚焦于高血压。
Int J Womens Health. 2014 Jan 24;6:131-9. doi: 10.2147/IJWH.S38084. eCollection 2014.
5
Membrane estrogen receptors: their role in blood pressure regulation and cardiovascular disease.膜雌激素受体:在血压调节和心血管疾病中的作用。
Curr Hypertens Rep. 2014 Jan;16(1):408. doi: 10.1007/s11906-013-0408-6.
6
Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.全基因组范围内对镰状细胞病患儿收缩压的荟萃分析。
PLoS One. 2013 Sep 13;8(9):e74193. doi: 10.1371/journal.pone.0074193. eCollection 2013.
7
Sex differences in primary hypertension.原发性高血压的性别差异。
Biol Sex Differ. 2012 Mar 14;3(1):7. doi: 10.1186/2042-6410-3-7.
8
Non-pharmacological aspects of blood pressure management: what are the data?血压管理的非药物方面:有哪些数据?
Kidney Int. 2011 May;79(10):1061-70. doi: 10.1038/ki.2011.46. Epub 2011 Mar 9.
9
Thirty-year Survival for Black and White Hypertensive Individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program.埃文斯县心脏研究及高血压检测与随访项目中黑人和白人高血压患者的30年生存率
J Am Soc Hypertens. 2008 Nov-Dec;2(6):448-54. doi: 10.1016/j.jash.2008.05.007.
10
Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study.血管紧张素受体阻滞剂/利尿剂联合治疗血压反应的预测因素:厄贝沙坦/氢氯噻嗪在不同患者群体中降低血压情况的二次分析(包容性)研究
J Clin Hypertens (Greenwich). 2008 Jan;10(1):27-33. doi: 10.1111/j.1524-6175.2007.07195.x.